Boston Scientific Announces Results For Third Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Boston Scientific (BSX) Tops Q3 EPS by 1c, Offers Guidance
October 27, 2021 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $2.93 billion versus the consensus estimate of $2.97 billion.
GUIDANCE:
Boston Scientific sees Q4 2021 EPS of $0.43-$0.45, versus the consensus of $0.44.
The company now estimates net sales growth for the full year... More


